- Home
- GHRS vs PCT Comparison
GHRS vs PCT Comparison
Compare GHRS & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | PCT |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Ireland | United States |
| Employees | N/A | 174 |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 955.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | PCT |
|---|---|---|
| Price | $21.74 | $12.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $41.38 | $13.00 |
| AVG Volume (30 Days) | 260.1K | ★ 4.4M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $380.44 |
| Revenue Next Year | N/A | $203.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.67 | $4.93 |
| 52 Week High | $24.66 | $17.37 |
Technical Indicators
Market Signals| Indicator | GHRS | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 87.81 |
| Support Level | $12.41 | $12.54 |
| Resistance Level | $22.88 | $14.95 |
| Average True Range (ATR) | 1.42 | 0.78 |
| MACD | -0.10 | 0.50 |
| Stochastic Oscillator | 61.56 | 92.62 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About PCT PureCycle Technologies Inc.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.